Headquarters and industrial site
Route de Bordeaux
47700 Casteljaloux
France
Commercial office
18-22 rue Marius Aufan
92300 Levallois-Perret
France
In the pharmaceutical manufacturing ecosystem, pharmaceutical CDMOs (Contract Development and Manufacturing Organizations) play a major role.
By integrating packaging into their production chain, they provide brands and laboratories with reliable technical solutions that comply with regulatory requirements.
In the pharmaceutical manufacturing ecosystem, pharmaceutical CDMOs (Contract Development and Manufacturing Organizations) play a major role.
By integrating packaging into their production chain, they provide brands and laboratories with reliable technical solutions that comply with regulatory requirements.
This article examines how CDMOs can offer expert technical solutions to meet the regulatory and industrial challenges of their clients.
CDMO stands for Contract development and manufacturing organization.
A pharmaceutical CDMO is a subcontracting company in the pharmaceutical industry. It handles one or more stages of the production chain:
A CDMO works on behalf of laboratories, pharmaceutical brands, or dietary supplement manufacturers.
The concept of a pharmaceutical CDMO therefore refers to a specialized industrial partner that supports its clients in the technical and regulatory implementation of their products, up to the final packaging.
products and dietary supplements. It is the first packaging that comes into direct contact with the active substance.
In addition to its role as a container, it directly contributes to the safety, stability, and quality of the product. It protects the active ingredient from oxidation, moisture, light, Primary packaging is a major component in the manufacturing of pharmaceutical and contamination, ensuring optimal preservation until final use.
In the pharmaceutical and nutraceutical industries, primary packaging is strictly regulated and must comply with the standards of the European Pharmacopoeia.
Calling upon a pharmaceutical CDMO ensures the security of this step. With its technical and regulatory expertise, the pharmaceutical CDMO helps clients make the right primary packaging choices. It can also integrate this choice into a comprehensive manufacturing process, ensuring consistency, compliance, and industrial performance.
To learn everything about primary packaging of drugs, check out our dedicated article.
Today, pharmaceutical CDMOs offer comprehensive services, covering all stages of the manufacturing of a health or nutrition product, including its packaging:
Primary packaging is therefore integrated into the manufacturing process, with equipment tailored to the dosage forms and specific materials.
Partnering with a pharmaceutical CDMO offers several benefits for laboratories and brands, including:
Liquid dietary supplements present specific challenges in formulation and packaging. Many plant extracts, vitamins, or natural active ingredients are sensitive to oxidation, light, or heat. Their stability mainly depends on the choice of primary packaging.
A pharmaceutical CDMO provides a comprehensive technical solution to these challenges. It selects packaging suited to the nature of the product, considering protection, preservation, and regulatory compliance requirements. It may recommend the use of glass containers (ILLAX® Type III glass or FIOLAX® Type I), such as double-tip ampoules, combined with vacuum filling to minimize the presence of air.
This solution helps extend the product’s shelf life while ensuring maximum protection of the active ingredients. Additionally, devices like the DRB (Double Ring Break), a patented expertise by SFAM, pre-determining the breaking point, secure the opening and minimize the risk of glass particles, a critical concern in the field of consumable products.
To learn more about the types of pharmaceutical glass, read our full article.
Injectable medications have high requirements in terms of stability, sterility, and safety. The active ingredients they contain can be unstable when exposed to light, air, or certain contaminants.
A pharmaceutical CDMO has the expertise required to select suitable materials, such as Type I borosilicate glass, which complies with the European Pharmacopoeia standards. This material offers very high chemical and thermal resistance, making it the standard for sensitive injectable solutions.
The CDMO can also go beyond the production of primary packaging by implementing automated vacuum filling processes carried out in controlled environments.
Primary packaging is a technical and strategic element of pharmaceutical manufacturing. Its quality directly impacts the safety, stability, and compliance of the finished product.
By integrating primary packaging into their overall offering, pharmaceutical CDMOs are able to meet these requirements. Their expertise allows them to select the right materials, optimize filling processes, and ensure compliance with regulatory standards.
Therefore, calling upon a CDMO ensures the security of each production step with a single expert market partner. It is also a lever to save time, reduce costs, and improve the overall quality of the product.